http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#Head
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#assertion
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#provenance
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#pubinfo
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#assertion
http://purl.obolibrary.org/obo/DOID_10456
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_10456
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00833
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association
http://www.w3.org/2000/01/rdf-schema#label
cefaclor is indicated in the treatment of the following infections when caused by susceptible strains of the designated microorganisms otitis media streptococcus pneumoniae haemophilus influenzae streptococcus pyogenes note b haemophilus influenzae in vitro lower respiratory tract infections streptococcus pneumoniae haemophilus influenzae streptococcus pyogenes note b haemophilus influenzae in vitro pharyngitis and tonsillitis streptococcus pyogenes note urinary tract infections escherichia coli proteus mirabilis klebsiella skin and skin structure infections staphylococcus aureus streptococcus pyogenes appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefaclor to reduce the development of drug resistant bacteria and maintain the effectiveness of cefaclor for oral suspension and other antibacterial drugs cefaclor for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00833
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#provenance
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#pubinfo
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#sig
http://purl.org/nanopub/x/hasSignature
e2vlEHWjCWhhij+qyvNtmA0CjEWguKeGXOAJNtnzHkLQFiw7tRoKS2JaEkWQ+VcOhJFxPSwnGkjR1iWIiIGvBe3qVq4NvyrwjOnVqemSN+7S27ayqGfYf+aR8fyxaCxlDl7HZiEbAu78LQQciRFv59dSDvVHontAwx85yKDJfh4=
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI
http://purl.org/dc/terms/created
2021-06-13T12:09:47.600+02:00
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAh20ev1spDxRFWkxXHTSu5btbk6C82lEJVgLSDNjjvbI
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs